Literature DB >> 28669050

The presence of aberrant p53 pattern is a negative prognostic predictor in squamous cell carcinoma of the nasal vestibule.

Domenic Vital1, Gerhard F Huber2, David Holzmann2, Holger Moch3, Kristian Ikenberg3.   

Abstract

The aim of this study was to analyze the role of Ki-67, p53, and the "aberrant p53 pattern" in squamous cell carcinomas of the nasal vestibule. Patients between 1995 and 2014 were included. Baseline characteristics and outcome were analyzed with respect to immunohistochemical staining of Ki-67 and p53. "Aberrant p53 pattern" was represented by a moderate or strong staining of at least 60% of the tumor cells or a complete absence of immunoreactivity. Forty-six patients were included of whom 31 (67.4%) were available for Ki-67 and 32 (69.9%) for p53 immunohistochemistry. The "aberrant pattern" of p53 was present in 50% of the patients. While immunoreactivity for both Ki-67 and p53 was not related to each other or outcome, the "aberrant p53 pattern" was associated with a worse disease-free survival (p = 0.014). The "aberrant p53 pattern" is a negative prognostic factor in squamous cell carcinoma of the nasal vestibule and might enable a patient-tailored treatment.

Entities:  

Keywords:  Aberrant pattern; Ki-67; Nasal vestibule; Predictor; Squamous cell carcinoma; p53

Mesh:

Substances:

Year:  2017        PMID: 28669050     DOI: 10.1007/s00405-017-4659-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  50 in total

1.  Mutational spectra and immunohistochemical analyses of p53 in human cancers.

Authors:  W P Bennett; M C Hollstein; I C Hsu; D Sidransky; D P Lane; B Vogelstein; C C Harris
Journal:  Chest       Date:  1992-03       Impact factor: 9.410

2.  Irradiation of localized squamous cell carcinoma of the nasal vestibule.

Authors:  Ben G L Vanneste; Marta Lopez-Yurda; I Bing Tan; Alfons J M Balm; Gerben R Borst; Coen R Rasch
Journal:  Head Neck       Date:  2015-12-26       Impact factor: 3.147

3.  Radiation therapy of squamous cell carcinoma of the nasal vestibule.

Authors:  P C Levendag; J Pomp
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-12       Impact factor: 7.038

4.  Radiation therapy for nasal vestibule squamous cell carcinoma: a 40-year experience.

Authors:  Justin Wray; Christopher G Morris; Jessica M Kirwan; Robert J Amdur; John W Werning; Peter T Dziegielewski; William M Mendenhall
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-13       Impact factor: 2.503

5.  Squamous cell cancer of the nasal cavity: New insights and implications for diagnosis and treatment.

Authors:  Christoph Becker; Gian Kayser; Jens Pfeiffer
Journal:  Head Neck       Date:  2016-02-08       Impact factor: 3.147

6.  Prognostic indicators in carcinoma of the nasal vestibule.

Authors:  J-P Jeannon; P J Riddle; J Irish; B O'sullivan; D H Brown; P Gullane
Journal:  Clin Otolaryngol       Date:  2007-02       Impact factor: 2.597

7.  T stage as prognostic factor in irradiated localized squamous cell carcinoma of the nasal vestibule.

Authors:  Eelco Kummer; Coen R N Rasch; Ronald B Keus; I Bing Tan; Alfons J M Balm
Journal:  Head Neck       Date:  2002-03       Impact factor: 3.147

Review 8.  Post-translational modification of p53 in tumorigenesis.

Authors:  Ann M Bode; Zigang Dong
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

9.  Relationships between p53 mutation, HPV status and outcome in oropharyngeal squamous cell carcinoma.

Authors:  Angela Hong; Xiaoying Zhang; Deanna Jones; Anne-Sophie Veillard; Mei Zhang; Andrew Martin; J Guy Lyons; C Soon Lee; Barbara Rose
Journal:  Radiother Oncol       Date:  2016-03-04       Impact factor: 6.280

10.  Outcome in squamous cell carcinoma of the nasal vestibule: a single center experience.

Authors:  Domenic Vital; Grégoire Morand; Gerhard F Huber; Gabriela Studer; David Holzmann
Journal:  Head Neck       Date:  2014-04-15       Impact factor: 3.147

View more
  1 in total

Review 1.  Novel Biomarkers in Sinonasal Cancers: from Bench to Bedside.

Authors:  Matt Lechner; Jacklyn Liu; Valerie J Lund
Journal:  Curr Oncol Rep       Date:  2020-07-29       Impact factor: 5.075

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.